A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I.
about
A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@en
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@nl
type
label
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@en
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@nl
prefLabel
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@en
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@nl
P2093
P2860
P1476
A phase I study of mTOR inhibi ...... nced cervix cancer: PHOENIX I.
@en
P2093
Andréia Cristina de Melo
Bruna Novaes Neto
Carlos Gil Ferreira
Felipe Erlich
Flávia Vieira Guerra Alves
Giulliana Moralez
Juliane Morando
Mariane S Fontes Dias
Mateus Fuchshuber-Moraes
Michel Carneiro
P2860
P2888
P304
P356
10.1007/S00280-016-3064-0
P577
2016-05-20T00:00:00Z